fbpx
FDR Station, PO Box 220
New York, NY 10150
1-800-ALZINFO (259-4636)
Phone: 1-212-915-1328
Email: info@alzinfo.org
CLOSE X
alzheimer's causes
Understanding Alzheimer’s DiseaseTop Ten Signs of Alzheimer’sClinical Stages of Alzheimer’sAlzheimer’s Disease Facts and StatisticsDementia vs Alzheimer’sYour Brain and Alzheimer’sSenile DementiaClinical Trials FAQsClinical Trials
alzheimer's care
CaregivingCaregiver’s CornerTherapeutic ActivitiesTips for the Caregivers from DoctorsDiet, Exercise & HealthCaregivers in TrainingHome ModificationContinuing CareBereavement and GriefLegal & Financial Planning
alzheimer's cure
Alzheimer’s ResearchAbout Our ResearchOur Research TeamProgress ReportsExplore Alzheimer’s Research
About Fisher Center FoundationAlzheimer’s NewsVideosResource LocatorMemory WallPreserving Your Memory® MagazineAsk The Experts
Copyright © 2023 The Fisher Center for Alzheimer's Research Foundation, a 501c3 not for profit,Tax ID # 13-3859563

LATEST ALZHEIMER'S RESEARCH NEWS YOU CAN USE

Expert reviewed Alzheimer’s and Dementia News

Category: Drugs and Treatment

Could an Exercise Pill One Day Protect Against Alzheimer’s?
September 20, 2023
Regular exercise has been linked to a range of benefits for the body, including the brain. Middle-aged people who are…
Learn More
Experimental Alzheimer’s Drug, Donanemab, Shows Promise
August 9, 2023
An experimental drug for Alzheimer’s showed promise in slowing declines in thinking and memory skills when given early in the…
Learn More
Leqembi drug for Alzheimer's
Leqembi Gets FDA Approval
July 12, 2023
On July 6th, the Food and Drug Administration granted full approval to a new treatment for Alzheimer’s disease called Leqembi.…
Learn More
Alzheimer's Patient - Alzheimer's Problems
New Drug to Combat Common Problem in Alzheimer’s Patients
June 14, 2023
The Food and Drug Administration recently approved the first drug specifically to treat agitation in people with Alzheimer’s disease. The…
Learn More
Boost Memory with Multivitamins
Take These for a Memory Boost!
June 14, 2023
A daily multivitamin boosted memory skills in older adults, according to a large new study. The findings, from researchers at…
Learn More
Leqembi drug for Alzheimer's
5 Things to Know About the New Alzheimer’s Drug, Leqembi 
January 11, 2023
On  January 6th, the Food and Drug Administration approved, via the Accelerated Approval pathway, a new treatment for Alzheimer’s…
Learn More
This Powerhouse Berry Boosts Brain Power
July 13, 2022
Experts often advise a heart-healthy diet rich in fruits and vegetables for optimal brain health. Now a new study suggests…
Learn More
Does Talk Therapy Have An Impact on Alzheimer’s?
June 28, 2022
Depression is common in people with Alzheimer’s disease, and people with the condition are often prescribed antidepressants and other behavior-modifying…
Learn More
Old Drug May Offer New Tricks for Alzheimer’s Disease
November 8, 2021
A drug that has been used for decades to treat fluid buildup in the body showed promise in preventing Alzheimer’s…
Learn More
Stimulant Drug May Reduce Apathy in People With Alzheimer’s Disease
October 18, 2021
The drug methylphenidate, a stimulant also known as Ritalin, may reduce apathy in people with Alzheimer’s disease. The benefits were…
Learn More
Drugmaker Eli Lilly to Seek Approval for New Alzheimer’s Drug, Donanemab
July 13, 2021
The drugmaker Eli Lilly announced that it will seek fast approval from the Food and Drug Administration for a new…
Learn More
Alzheimer's drug Aduhelm
What You Need to Know About the New Alzheimer’s Drug Aduhelm
July 13, 2021
In June, the Food and Drug Administration approved the new drug Aduhelm for people with Alzheimer’s disease. It was the…
Learn More
FDA Approves First New Alzheimer’s Drug in 18 Years
June 8, 2021
The Food and Drug Administration approved the first new Alzheimer’s drug in nearly two decades. The drug, called aducanumab, will…
Learn More
Experimental Drug, Donanemab, Shows Promise in Slowing Alzheimer’s
January 5, 2021
An experimental drug called donanemab showed promise in slowing the decline of Alzheimer’s disease in a medium-size clinical trial. People…
Learn More
New Drug, Aducanumab, Fails to Advance in Expert Review
December 10, 2020
A panel of medical experts recommended strongly against approval for a new drug for Alzheimer’s disease that is up for…
Learn More
Three Fourths of Alzheimer’s Patients Are on Risky Medications
November 24, 2020
Nearly three quarters of people with Alzheimer’s disease or other forms of dementia are on medications that were not specifically…
Learn More
A Reminder to Keep Taking Your Blood Pressure Medications
June 19, 2020
Many people have been putting off doctor visits or prescription refills because of fears about visiting the doctor’s office or…
Learn More
Senior Man taking pills
Take Your Blood Pressure Meds. It May Reduce Your Alzheimer’s Risk.
January 15, 2020
Here’s another reason to take your blood pressure medications: Keeping your blood pressure in check in middle age may reduce…
Learn More
Drug Company to Pursue Approval of Aducanumab, New Drug for Alzheimer’s
January 15, 2020
The drug company Biogen is seeking approval for an experimental drug called aducanumab for treating people in the early stages…
Learn More
Drugs May Not Be the Best Choice for Easing the Agitation of Alzheimer’s
November 11, 2019
Massage, touch therapy, exercise, music therapy and other non-drug treatments can be an effective way to reduce aggression and agitation…
Learn More
Alzheimer’s Drug May Lead to Life-Threatening Muscle Disease
October 2, 2019
Many people with Alzheimer’s disease take the drug donepezil (brand name Aricept) to help ease symptoms for a time. But…
Learn More
Opiods Pain Killers Risk Alzheimer's
Opioid Painkillers Increase Pneumonia Risk in People With Alzheimer’s Disease
August 20, 2019
People with Alzheimer’s disease who are treated with opioid painkillers are at increased risk of developing pneumonia. The risk was…
Learn More
Drug Companies Halt Trials of Aducanumab for Alzheimer’s Disease
July 2, 2019
The drug makers Biogen and Eisai have decided to abandon late-stage testing of a promising new drug for Alzheimer’s disease,…
Learn More
Diabetes Treatments May Help Ward Off Alzheimer’s Disease
June 6, 2019
People with Type 2 diabetes should be treated promptly for their disease, which will not only help to manage their…
Learn More
Next
WE CAN END ALZHEIMER'S

We support the pioneering research of the late Nobel Laureate Dr. Paul Greengard under the leadership of Dr. Nathaniel Heintz and his team as they continue pursuing the quest for a cure.

DONATE FOR THE CURE
We consistently receive top awards and ratings for our accountability:
Charity Navigator
GuideStar Gold Seal of Transparency
America's Best Charities
Combined Federal Campaign
Health and Medical Research Charities of America
Digital Health Awards

Connect with Us

Mailing Address:
The Fisher Center for Alzheimer's Research Foundation
FDR Station, PO Box 220
New York, NY 10150

1-800-ALZINFO (259-4636)
Phone: 1-212-915-1328
Email: info@alzinfo.org

Top Links

Understanding Alzheimer’s DiseaseAlzheimer's DiagnosisDementia vs. Alzheimer'sTop Ten Signs of Alzheimer'sClinical Stages of Alzheimer’s

About Fisher

About UsFinancialsTerms of ServicePrivacy Policy501 C 3 Letter

Information Program

Alzheimer’s NewsPreserving Your Memory® MagazineResource LocatorCaregiver’s CornerVideos
Copyright © 2023 The Fisher Center for Alzheimer's Research Foundation, a 501c3 not for profit,Tax ID # 13-3859563